One of the key players in both hemostasis and thrombosis is von Willebrand factor (vWF),
which demonstrates a duality between these two processes. Thrombus is structured by …

Expert recommendations on the assessment of wall shear stress in human coronary arteries:
existing methodologies, technical considerations, and clinical applications | European Heart …

The biophysics of blood flow can dictate the function of molecules and cells in the
vasculature with consequent effects on hemostasis, thrombosis, embolism, and fibrinolysis …

Ventricular assist devices (VADs), among which the HeartMate 3 (HM3) is the latest clinically
approved representative, are often the therapy of choice for patients with end‐stage heart …

The common complications in heart failure patients with implanted ventricular assist devices
(VADs) include hemolysis, thrombosis, and bleeding. These are linked to shear stress …

BACKGROUND: There is a paucity of data on the underlying procoagulant–anticoagulant
balance during extracorporeal membrane oxygenation (ECMO). We hypothesized that adult …

A plethora of leukocyte modulations have been reported in critically ill patients. Critical
illnesses such as acute respiratory distress syndrome and cardiogenic shock, which …

Methods In this study, we developed a microfluidic chip model that can mimic normal
arteries and stenotic arterial vessels, and studied the inhibitory effects of TMA on platelet …

Objective To review the use of Von Willebrand Factor (VWF) concentrate for treatment of
acquired Von Willebrand syndrome (VWS)-related bleeding in adult extracorporeal …

Background Patients with continuous flow ventricular assist devices (CF‐VADs) are at high
risk for non‐surgical bleeding, speculated to associate with the loss of pulsatility following …